Globus Medical Inc (GMED)
75.08 +1.69 (+2.30%) 14:51 ET [NYSE]
75.04 x 5 75.13 x 4
Realtime by (Cboe BZX)
75.04 x 5 75.13 x 4
Realtime - - (-) -
for Wed, Apr 2nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 2,519,355 | 1,568,476 | 1,022,843 | 958,102 | 789,042 |
Cost of Goods | 1,035,479 | 548,174 | 263,725 | 239,223 | 217,463 |
Gross Profit | 1,483,876 | 1,020,302 | 759,118 | 718,879 | 571,579 |
Operating Expenses | 1,318,364 | 887,334 | 531,892 | 547,149 | 460,609 |
Operating Income | 165,991 | 133,142 | 227,951 | 171,953 | 111,433 |
Other Income | -45,269 | 32,251 | 15,068 | 8,454 | 14,466 |
Pre-tax Income | 120,722 | 165,393 | 243,019 | 180,407 | 125,899 |
Income Tax | 17,738 | 42,520 | 52,850 | 31,216 | 23,614 |
Net Income Continuous | 102,984 | 122,873 | 190,169 | 149,191 | 102,285 |
Net Income | $102,984 | $122,873 | $190,169 | $149,191 | $102,285 |
EPS Basic Total Ops | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 |
EPS Basic Continuous Ops | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 |
EPS Diluted Total Ops | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 |
EPS Diluted Continuous Ops | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 |
EPS Diluted Before Non-Recurring Items | 3.04 | 2.32 | 2.06 | 2.04 | 1.44 |
EBITDA(a) | $661,430 | $358,500 | $301,592 | $244,601 | $174,894 |